Occudo Quantitative Strategies LP Arrowhead Pharmaceuticals, Inc. Transaction History

Occudo Quantitative Strategies LP

  • $501 Million
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$29.63 - $48.31 $1.08 Million - $1.76 Million
36,343 Added 198.28%
54,672 $1.81 Million
Q2 2022

Aug 15, 2022
SELL
$27.79 - $50.61 $246,691 - $449,264
-8,877 Reduced 32.63%
18,329 $645,000
Q1 2022

May 16, 2022
BUY
$39.62 - $69.97 $1.08 Million - $1.9 Million
27,206 New
27,206 $1.25 Million
Q1 2021

May 14, 2021
SELL
$61.35 - $90.47 $377,179 - $556,209
-6,148 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$43.82 - $85.37 $269,405 - $524,854
6,148 New
6,148 $472,000

Others Institutions Holding ARWR

# of Institutions
294
Shares Held
90.8M
Call Options Held
155K
Put Options Held
426K
View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

ARWR Quotes by TradingView
  • Ticker ARWR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 105,849,000
  • Market Cap $2.07B
  • Description
  • Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...
More about ARWR
Track This Portfolio

Track Occudo Quantitative Strategies LP Portfolio

Follow Occudo Quantitative Strategies LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

News

Stay updated on Occudo Quantitative Strategies LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email